IP Library Granted Patent US 8,012,901
Granted Patent B1
US 8,012,901 · App. 12/386,356 · Granted Sep 6, 2011

Method of synthesizing enantiopure mexiletine analogues and novel β-thiophenoxy and pyridyl ethers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,012,901
App. No.
12/386,356
Granted
Sep 6, 2011
Kind
B1
Abstract

A practical and efficient procedure for the enantioselective synthesis of mexiletine analogues using 10% of a novel spiroborate ester as chirality transfer agent is presented. A variety of mexiletine analogues were prepared with excellent enantioselectivities (91-97% ee) in good yield from readily available starting materials. The developed methodology was also successfully applied for the synthesis of novel β-amino ethers containing thiophenyl and pyridyl fragments.

Claims (44)

1. A method of synthesizing enantiopure Mexiletine Analogues and Novel β-Thiophenoxy and Pyridyl ethers comprising: reducing an O-benzyl oxime having the formula I:

where R is a substituted or unsubstituted, alkyl, aryl group; Y is an oxygen atom or a sulfur atom and Ar is an aryl, alkyl, Pyridyl group; wherein said reduction is done in the presence of a catalyst agent having the formula II:

where, the R and R1 groups are equal or different; a hydrogen atom or a substituted or unsubstituted, aryl, alkyl, cycloalkyl or aralkyl; R2 and R 3 groups are different; a hydrogen atom or a substituted or unsubstituted, alkyl, aryl, aralkyl group; and the R4 group is a H or a cycloalkyl or aralkyl group; and wherein the substituents R, R1, R2, R3, and R4 groups are substantially non-reactive.

2. The method of claim 1 , wherein said O-benzyl oxime is reduced to form a mexiletine analogue having the formula III:

where, R is an aryl, alkyl group; Y is an oxygen atom or sulfur atom and Ar is an aryl, alkyl, Pyridyl group.

3. The method of claim 2 , wherein said mexiletine analogue comprises:

4. The method of claim 2 , wherein said mexiletine analogue comprises:

5. The method of claim 2 , wherein said mexiletine analogue comprises:

6. The method of claim 2 , wherein said mexiletine analogue comprises:

7. The method of claim 2 , wherein said mexiletine analogue comprises:

8. The method of claim 2 , wherein said mexiletine analogue comprises:

9. The method of claim 2 , wherein said mexiletine analogue comprises:

10. The method of claim 2 , wherein said mexiletine analogue comprises:

11. The method of claim 2 , wherein said mexiletine analogue comprises:

12. The method of claim 2 , wherein said mexiletine analogue comprises:

13. The method of claim 2 , wherein said mexiletine analogue comprises:

14. The method of claim 2 , wherein said reduction produces an amine comprising:

15. The method of claim 2 , wherein said reduction produces an amine comprising:

16. The method of claim 2 , wherein said reduction produces an amine comprising:

17. The method of claim 2 , wherein said reduction produces an amine comprising:

18. The method of claim 2 , wherein said reduction produces an amine comprising:

19. The method of claim 1 , wherein said catalyst agent comprises:

20. The method of claim 1 , wherein said catalyst agent comprises:

21. The method of claim 1 , wherein said catalyst agent comprises:

22. The method of claim 1 , wherein said catalyst agent comprises:

23. The method of claim 1 , wherein said catalyst agent comprises:

24. The method of claim 1 , wherein the catalyst agent is able to reduce said oxime to obtain an enantioselectivity of at least 91%.

25. The method of claim 1 , wherein the catalyst agent is able to reduce said oxime to obtain an enantioselectivity of from about 91% to about 97%.

26. The method of claim 1 , comprising:

adding anhydrous dioxane and BH3.THF in one portion to a reaction tube with said catalyst agent under N 2 .

27. The method of claim 26 , further comprising:

stirring the mixture for a first period of time at a first predetermined temperature; and

cooling said mixture at a second predetermined temperature.

28. The method of claim 27 , further comprising:

adding benzyl oxime in dioxane to the cooled mixture dropwise for a second period of time.

29. The method of claim 28 , further comprising:

stirring the resulting mixture at said second predetermined temperature until the conversion is completed.

30. The method of claim 26 , wherein 10 mL of anhydrous dioxane and at least 4 mL of BH3.THF (1M in THF) in one portion are added to a reaction tube with 33 mg (0.1 mmol) of said catalyst agent under N 2 .

31. The method of claim 27 , wherein:

said first period of time is 1 hour;

said first predetermined temperature is about room temperature; and

said second predetermined temperature is about 0° C.

32. The method of claim 28 , wherein 1 mmol of benzyl oxime in 5 ml of dioxane is added to the cooled mixture dropwise for about 1 hour.

33. The method of claim 29 , wherein said second predetermined temperature is about 0° C. and said conversion is completed in about 48 hours.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 1, 2010
From: UNIVERSITY OF PUERTO RICO MED SCIENCES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024461/0269 →
Continuity (1)
Continuation In Part 11512599 · Aug 30, 2006